Equities

Aspen Aerogels Inc

Aspen Aerogels Inc

Actions
  • Price (EUR)22.20
  • Today's Change0.600 / 2.78%
  • Shares traded500.00
  • 1 Year change+326.92%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 07:16 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Aspen Aerogels Inc grew revenues 32.35% from 180.36m to 238.72m while net income improved from a loss of 82.74m to a smaller loss of 45.81m.
Gross margin36.43%
Net profit margin0.39%
Operating margin2.57%
Return on assets0.20%
Return on equity0.30%
Return on investment0.23%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Aspen Aerogels Inc fell by 142.59m. Cash Flow from Financing totalled 75.48m or 31.62% of revenues. In addition the company used 42.61m for operations while cash used for investing totalled 175.46m.
Cash flow per share0.3033
Price/Cash flow per share85.99
Book value per share6.72
Tangible book value per share6.72
More ▼

Balance sheet in USDView more

Aspen Aerogels Inc has a Debt to Total Capital ratio of 19.51%, a lower figure than the previous year's 26.00%.
Current ratio3.46
Quick ratio2.82
Total debt/total equity0.2425
Total debt/total capital0.1951
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.